LOADING

COVID COCKTAIL LIQUID

$60.00

Description

 

The argument for effective treatments and vaccines for the COVID-19 virus depends largely on which side of the coin you are own.  For me and my house, it is the side that says effective treatment without side effects and unproven long-term studies.  As a Clinical Research Scientist, I’m privy to too much information as it relates to drugs and pharmaceuticals.  I think we should be armed with all the information so that we can make an informed decision if the vaccine is right for you.  I will not use this platform to say whether or not you should take the vaccine. I’m here to say that you should be educated about EVERY potential treatment for this deadly virus.

The Race To Cure, was a sprint rather than a marathon. Over 6 vaccines within 6 months is nothing short of a miracle (side-eye, intended).  We are either the smartest creations on the planet (and we are), but if that wasn’t coupled with being the dumbest ones then I would be confident in our ability to sequence, isolate and synthesize this virus in record timing.  In other countries, there are several vitamins, minerals, herbs, and plants that have shown effective treatment (cure is not allowed to be said) for COVID-19.  Yet these reports exist freely in other countries about the effectiveness of these alternatives.   Our COVID COCKTAIL was formulated with a growing understanding and completely accurate studies that show how Artemesia Annua (and it’s derivatives), Vitamin C, Vitamin D, Elderberry, Ginger-Based Drinks have been amazingly great treatment options with NO KNOWN SIDE EFFECTS!

The Covid Cocktail uses all the power and wisdom of great herbal medicine.  Our proprietary blend of herbs along with Artemesia Annua or Absinthe, Ginger, Soursop, Echinacea, Astragalas, Elderberry, Pineapple, Vitamin D, Lemongrass, Muellin, Tumeric and Honey.  IT DOESN’T TASTE GREAT GOING DOWN!   BUT !!!  YOU WANT COVID GONE!  Please research several articles regarding herbs like Artemesia Annua for COVID-19

64 oz Bottle, Must be refridgerated

DOSAGE :  8 oz 3x daily

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276816/

Abstract

In December 2019, a number of pneumonia cases associated with 2019 novel coronavirus occurred in Wuhan, China. Later taxonomist name the virus SARS‐CoV‐2 and disease called COVID‐19. No approved vaccine or treatment are available for this virus. Current technical guide is related to address therapeutic option for SARS‐CoV‐2. COVID‐19 is great challenge for scientist across the globe. Bioactive compound present in Artemisia annua against, hepatitis B virus, bovine viral diarrhea virus, and Epstein–Barr virus. A. annua have shown significant activity against SARS coronavirus that occur in 2002. This agent is cheap and easily available and will be of great value if they have efficacy against SARS‐CoV‐2. Scientific attention is needed toward this agent to address for the treatment of COVID‐19.

Keywords: Artemisia annua, bioactive compound, coronavirus: antiviral agents: COVID‐19, SARS‐CoV‐2

1.

Beginning in December 2019, an increasing number of cases of novel coronavirus, designated SARS‐CoV‐2, has caused worldwide outbreak of respiratory infection now termed coronavirus disease 2019 (COVID‐19) (Cao et al., 2020). As of March 26, 2020, coronavirus disease 2019 (COVID‐19) has been confirmed in 462,684 people and the death had reached over 20,834 globally (WHO, 2020). Until yet, there are no vaccine and no specific antiviral agents for coronavirus infections, so it is a great challenge for scientists to find antiviral agent to treat this disease. Researcher endeavoring for antiviral agents, some of them are natural products, ritonavir, chloroquine phosphate, arbidol, ribavirin, and traditional Chinese medicines that demonstrated preliminary efficacy against SARS‐CoV, the virus that causes SARS in humans (Dong, Hu, & Gao, 2020). Scientific attention is needed toward efficacious therapies against COVID‐19.

There are relevant information regarding therapies from the 2002–2003 outbreak of SARS‐CoV in China. The researcher tested in vitro antiviral activities of Artemisia annua whole plants preparation in ethanolic extract against SARS‐CoV, with 50% effective concentration (EC50) value of 34.5 ± 2.6 μg/mL and 50% cytotoxic concentration (CC50) of 1,053 ± 92.8 μg/mL. The result affords strong support for the usage of A. annua to treat SARS‐CoV infectious diseases (Li et al., 2005). In China, natural compounds has been frequently used in combination with conventional medicine to treat SARS. Some evidence demonstrated that the traditional herbal medicine is effective against SARS‐CoV infectious diseases (Lin, Han, & Yang, 2003).

Artemisinin is derivatives of A. annua that have been commercialized as antimalarial drugs (Efferth et al., 2008). As well as the value of artemisinin is not limited to the treatment of malaria, it is most promising natural products that is important candidates accounting for the antiviral effects (Karamoddini, Emami, Ghannad, Sani, & Sahebkar, 2011). In addition A. annua contain sterols that show virus inhibitory potential (Khan, Jain, Bhakuni, Zaim, & Thakur, 1991).

Currently, there are supportive and nonspecific treatment to relieve patient symptom. For prophylaxis and treatment of virus the antiviral agent must be safe, adequate, and cost should be preferably low. In China, most of the infected patient receiving traditional Chinese medicine for treatment of COVID‐19 (Yang, Islam, Wang, Li, & Chen, 2020). The subset methanolic extracts obtained from aerial parts of A. annua had the highest antiviral activity than acyclovir against Herpes Simplex virus type 1. Aerial subsets extracts of A. annua contain bioactive compound that may be an appropriate candidate for antiviral therapies (Karamoddini et al., 2011). It has a history of being safe and easily available for therapies.

Pulmonary fibrosis are observed in SARS coronavirus‐2 (SARS‐CoV‐2) infection with increased severity, mediated by Interleukin‐1 (Conti et al., 2020). Several studies suggesting that oxidative stress is associated with pulmonary diseases and it is likely that the consumption of natural antioxidant are effective in lung fibrosis (Day, 2008). A. annua extract exhibit significant antioxidant activity that is most likely due to its high phenolic content (Ferreira, Luthria, Sasaki, & Heyerick, 2010). A. annua derivatives, artesunate, is a promising novel drug to treat pulmonary fibrosis by inhibiting pro‐fibrotic molecules associated with pulmonary fibrosis (Wang, Xuan, Yao, Huang, & Jin, 2015). The rationale for testing antioxidants and antifibrotic effect in A. annua is appealing that might play a key role in lung fibrosis.